Promises and controversies in the management of low-grade glioma
- PMID: 14630671
- DOI: 10.1093/annonc/mdg501
Promises and controversies in the management of low-grade glioma
Comment on
-
Phase II study of primary temozolomide chemotherapy in patients with WHO grade II gliomas.Ann Oncol. 2003 Dec;14(12):1715-21. doi: 10.1093/annonc/mdg371. Ann Oncol. 2003. PMID: 14630674 Clinical Trial.
-
Temozolomide chemotherapy for progressive low-grade glioma: clinical benefits and radiological response.Ann Oncol. 2003 Dec;14(12):1722-6. doi: 10.1093/annonc/mdg502. Ann Oncol. 2003. PMID: 14630675 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
